Prognostic Value of Pulse Oximetry Differences
Prognostic Significance of Multi-site Pulse Oximetry Differences in Dyspneic Emergency Department Patients
研究概览
地位
条件
详细说明
This is a prospective observational cohort study conducted in a single ED to evaluate the prognostic significance of inter-site differences in pulse oximetry in adult patients presenting with dyspnea.
Adult patients (≥19 years) presenting with dyspnea and classified as Korean Triage and Acuity Scale (KTAS) levels 1-3 will be enrolled at the time of ED admission. During initial vital sign assessment at ED presentation, SpO₂ will be simultaneously measured at the finger, earlobe, and forehead, along with the corresponding perfusion index at each site.
The primary exposure of interest is the difference between finger and earlobe SpO₂ (ΔSpO₂). Additional inter-site SpO₂ differences involving forehead measurements will also be evaluated. Clinical and physiological data at presentation will be collected prospectively, while outcome data will be obtained through retrospective medical record review.
The primary outcome is the mean difference in ΔSpO₂ between patients with poor outcomes-defined as all-cause mortality from ED admission to hospital discharge or intensive care unit (ICU) admission-and those with favorable outcomes. Secondary outcomes include the associations of ΔSpO₂ with mortality, ICU admission, endotracheal intubation, serum lactate levels, and perfusion index, as well as the predictive performance of ΔSpO₂ using logistic regression and receiver operating characteristic (ROC) analysis. The prognostic value of ΔSpO₂ will also be compared with established early warning scores such as NEWS.
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Stephen GW LEE, MD
- 电话号码:82-10-5124-8415
- 邮箱:leestephengyungwon@yuhs.ac
学习地点
-
-
Seoul
-
Seoul、Seoul、韩国、03722
- 招聘中
- Yonsei University Severance Hospital
-
接触:
- Stephen GW LEE, MD
- 电话号码:82-2-2228-2678
- 邮箱:LEESTEPHENGYUNGWON@YUHS.AC
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
取样方法
研究人群
描述
Inclusion Criteria:
- Adult patients aged 19 years or older presenting to the emergency department with dyspnea, classified as KTAS level 1-3
Exclusion Criteria:
- Patients in whom SpO₂ measurements were not obtained simultaneously
- Patients in whom arterial blood gas analysis was not ordered at initial evaluation
- Pregnant patients
- Patients with facial trauma or hand trauma
- Patients with amputation, injury, or burns at the measurement sites
- Patients wearing nail polish
- Patients with dyshemoglobinemia
- Non-Korean nationality
- Patients who did not provide consent to participate in the study
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
|---|
|
Dyspnea cohort
Patients visiting emergency department with dyspnea who are categorized to KTAS 1-3
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
In-hospital mortality or ICU admission
大体时间:From the index emergency department visit through hospital discharge, assessed up to 6 months.
|
In-hospital mortality or ICU admission of index visit
|
From the index emergency department visit through hospital discharge, assessed up to 6 months.
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 4-2025-1489
- 6-2025-0076 (其他赠款/资助编号:Yonsei University College of Medicine)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.